IL17A and neoplasm: They found that CR and PR patients had higher levels of GZMB+ MAIT and IFN-γ+ MAIT (anti-tumor MAIT) after treatment compared to SD patients, and CR and PR patients showed a reduction in IL-17A+ MAIT (pro-tumor MAIT) levels post-treatment, while PD and SD patients did not exhibit this difference [123].